Irritable Bowel Syndrome Trial, Recruiting (NCT06381921)

Irritable Bowel Syndrome Trial, Recruiting NCT06381921 Sponsor: University of Connecticut Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06381921 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS) by a doctor using standard diagnostic guidelines, and you currently experience stomach pain
You are a man or woman between 18 and 50 years old
You are able to read and speak English
You have daily access to a computer with an internet connection

Who may not be able to join:

You have other long-term pain conditions that are not commonly linked to IBS, such as diabetic nerve pain, muscle pain, lower back pain, or nerve damage in the hands or feet
You have celiac disease or inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
You have diabetes
You have a serious mental health condition (confirm with trial site for specific details)
You are currently pregnant or have given birth within the last 3 months
You regularly use opioid pain medications or illegal substances
If you have had COVID-19, you must be fully recovered, and you will be asked whether your doctor has placed any restrictions on your activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8604861556

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06381921

Sponsor: University of Connecticut

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: 8604861556

More information: https://clinicaltrials.gov/study/NCT06381921

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Irritable Bowel Syndrome (IBS) by a doctor using standard diagnostic guidelines, and you currently experience stomach pain
You are a man or woman between 18 and 50 years old
You are able to read and speak English
You have daily access to a computer with an internet connection

Who may not be able to join:

You have other long-term pain conditions that are not commonly linked to IBS, such as diabetic nerve pain, muscle pain, lower back pain, or nerve damage in the hands or feet
You have celiac disease or inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
You have diabetes
You have a serious mental health condition (confirm with trial site for specific details)
You are currently pregnant or have given birth within the last 3 months
You regularly use opioid pain medications or illegal substances
If you have had COVID-19, you must be fully recovered, and you will be asked whether your doctor has placed any restrictions on your activities

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Connecticut

Registry

ClinicalTrials.gov

Start date

8 September 2025

Est. completion

31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain intensity and interference; IBS-related symptoms; Electrodermal activity (EDA); Electrocardiogram (ECG); Electromyogram (EMG); Objective integrated multimodal electrophysiological index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov